Cargando…

Effect of palmitoylation on the dimer formation of the human dopamine transporter

The human dopamine transporter (hDAT) is one in three members of the monoamine transporter family (MAT). hDAT is essential for regulating the dopamine concentration in the synaptic cleft through dopamine reuptake into the presynaptic neuron; thereby controlling hDAT dopamine signaling. Dysfunction o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeppelin, Talia, Pedersen, Kasper B., Berglund, Nils A., Periole, Xavier, Schiøtt, Birgit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893171/
https://www.ncbi.nlm.nih.gov/pubmed/33602981
http://dx.doi.org/10.1038/s41598-021-83374-y
_version_ 1783653012547305472
author Zeppelin, Talia
Pedersen, Kasper B.
Berglund, Nils A.
Periole, Xavier
Schiøtt, Birgit
author_facet Zeppelin, Talia
Pedersen, Kasper B.
Berglund, Nils A.
Periole, Xavier
Schiøtt, Birgit
author_sort Zeppelin, Talia
collection PubMed
description The human dopamine transporter (hDAT) is one in three members of the monoamine transporter family (MAT). hDAT is essential for regulating the dopamine concentration in the synaptic cleft through dopamine reuptake into the presynaptic neuron; thereby controlling hDAT dopamine signaling. Dysfunction of the transporter is linked to several psychiatric disorders. hDAT and the other MATs have been shown to form oligomers in the plasma membrane, but only limited data exists on which dimeric and higher order oligomeric states are accessible and energetically favorable. In this work, we present several probable dimer conformations using computational coarse-grained self-assembly simulations and assess the relative stability of the different dimer conformations using umbrella sampling replica exchange molecular dynamics. Overall, the dimer conformations primarily involve TM9 and/or TM11 and/or TM12 at the interface. Furthermore, we show that a palmitoyl group (palm) attached to hDAT on TM12 modifies the free energy of separation for interfaces involving TM12, suggesting that S-palmitoylation may change the relative abundance of dimers involving TM12 in a biological context. Finally, a comparison of the identified interfaces of hDAT and palmitoylated hDAT to the human serotonin transporter interfaces and the leucine transporter interface, suggests similar dimer conformations across these protein family.
format Online
Article
Text
id pubmed-7893171
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-78931712021-02-23 Effect of palmitoylation on the dimer formation of the human dopamine transporter Zeppelin, Talia Pedersen, Kasper B. Berglund, Nils A. Periole, Xavier Schiøtt, Birgit Sci Rep Article The human dopamine transporter (hDAT) is one in three members of the monoamine transporter family (MAT). hDAT is essential for regulating the dopamine concentration in the synaptic cleft through dopamine reuptake into the presynaptic neuron; thereby controlling hDAT dopamine signaling. Dysfunction of the transporter is linked to several psychiatric disorders. hDAT and the other MATs have been shown to form oligomers in the plasma membrane, but only limited data exists on which dimeric and higher order oligomeric states are accessible and energetically favorable. In this work, we present several probable dimer conformations using computational coarse-grained self-assembly simulations and assess the relative stability of the different dimer conformations using umbrella sampling replica exchange molecular dynamics. Overall, the dimer conformations primarily involve TM9 and/or TM11 and/or TM12 at the interface. Furthermore, we show that a palmitoyl group (palm) attached to hDAT on TM12 modifies the free energy of separation for interfaces involving TM12, suggesting that S-palmitoylation may change the relative abundance of dimers involving TM12 in a biological context. Finally, a comparison of the identified interfaces of hDAT and palmitoylated hDAT to the human serotonin transporter interfaces and the leucine transporter interface, suggests similar dimer conformations across these protein family. Nature Publishing Group UK 2021-02-18 /pmc/articles/PMC7893171/ /pubmed/33602981 http://dx.doi.org/10.1038/s41598-021-83374-y Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Zeppelin, Talia
Pedersen, Kasper B.
Berglund, Nils A.
Periole, Xavier
Schiøtt, Birgit
Effect of palmitoylation on the dimer formation of the human dopamine transporter
title Effect of palmitoylation on the dimer formation of the human dopamine transporter
title_full Effect of palmitoylation on the dimer formation of the human dopamine transporter
title_fullStr Effect of palmitoylation on the dimer formation of the human dopamine transporter
title_full_unstemmed Effect of palmitoylation on the dimer formation of the human dopamine transporter
title_short Effect of palmitoylation on the dimer formation of the human dopamine transporter
title_sort effect of palmitoylation on the dimer formation of the human dopamine transporter
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893171/
https://www.ncbi.nlm.nih.gov/pubmed/33602981
http://dx.doi.org/10.1038/s41598-021-83374-y
work_keys_str_mv AT zeppelintalia effectofpalmitoylationonthedimerformationofthehumandopaminetransporter
AT pedersenkasperb effectofpalmitoylationonthedimerformationofthehumandopaminetransporter
AT berglundnilsa effectofpalmitoylationonthedimerformationofthehumandopaminetransporter
AT periolexavier effectofpalmitoylationonthedimerformationofthehumandopaminetransporter
AT schiøttbirgit effectofpalmitoylationonthedimerformationofthehumandopaminetransporter